Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
The rise of pro-NPE and patent sentiment in the US
Americas
The rise of pro-NPE and patent sentiment in the US
Non-practising entities are controversial, but political winds in the US are shifting and inventors, investors, and operating companies of all stripes should take note, writes Manny Caixeiro of Venable.   1 September 2025
Why the Caribbean cannabis economy is ripe for IP protection
Americas
Why the Caribbean cannabis economy is ripe for IP protection
With growing legislation, research and demand for medical use, cannabis presents an economic opportunity for the Caribbean—but IP rights in the region have some way to go, write Keesha Fleming Lake of Keesha Fleming Lake, and Rachael Lodge Corrie of Foga Daley.   28 August 2025
China filings push rise in patent applications in Ireland
Europe
China filings push rise in patent applications in Ireland
A high number of filings from China has driven patent applications up by nearly a third at Ireland’s intellectual property office, which also reported a rise in SPC applications and strong activity in the medtech sector.   28 August 2025
Americas
Brain disorder medtech rivals butt heads at ITC
Natus Medical retaliates against startup’s complaint in a patent clash over wearable diagnostic and monitoring products for neurological conditions.   27 August 2025
Europe
‘This is not a rescue deal’: How an acquisition fits London firm's plan
The executive chair of Beck Greener enabled a smaller firm to swerve private equity and join its stable—a move that boosts what was already a "clear path to growth" under his bold leadership, discovers Sarah Speight.   26 August 2025
Americas
Ninth Circuit revives trade secrets claims in DNA-sequencing spat
Plaintiff accuses defendant of “locking” employees out of office to steal secrets | Ruling rejects California’s stricter “reasonable particularity” rule for federal DTSA cases | Decision may shape plaintiffs’ choice of legal claims in future disputes in the state.   13 August 2025
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
Firm takes over Novartis in major patent litigation | Move follows rival firm's withdrawal after conflict-of-interest challenge | Latham team led by new hire from Cravath.   13 August 2025
Americas
Why Trump’s revenue-raising patent plan is riddled with problems
A patent fee structure being mooted in the US could hurt the innovation economy, especially in industries like biotech and pharma—and will face backlash from businesses, writes Paul Hunter of Foley.   12 August 2025
Americas
Harvard’s patent portfolio at risk as Trump turns up the pressure
Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts.   11 August 2025
Careers
Weil adds leaders from Latham to head up tech and life sciences
The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.   11 August 2025